Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?

Area of Science:

• Biochemistry
• Cell Biology
• Neuromuscular Disorders

Background:

• Mitochondrial stress is implicated in muscle weakness in inherited muscular dystrophies, particularly Duchenne muscular dystrophy (DMD).
• Existing research presents conflicting findings regarding mitochondrial ATP synthesis, reactive oxygen species (ROS) production, and apoptosis propensity in DMD.
• The heterogeneity in findings may stem from disease progression stage, muscle type, animal models, metabolic pathways, and experimental techniques.

Purpose of the Study:

• To critically review the literature on mitochondrial stress responses in Duchenne muscular dystrophy (DMD).
• To propose considerations for future experimental designs to address the heterogeneous nature of mitochondrial stress in DMD.
• To offer a renewed perspective on "mitochondrial dysfunction" as potentially adaptive reprogramming versus direct pathology.

Main Methods:

• Comprehensive literature review and analysis of existing studies on mitochondrial function in muscular dystrophies.
• Examination of factors influencing mitochondrial stress responses, including disease stage, tissue type, and methodology.
• Synthesis of divergent findings to identify patterns and propose future research directions.

Main Results:

• Mitochondrial ATP synthesis, ROS levels, and apoptosis propensity show inconsistent results across studies in DMD.
• The observed mitochondrial stress responses are highly dependent on disease progression, muscle specificity, preclinical models, and experimental assays.
• A nuanced understanding of mitochondrial stress as a potential adaptive response or direct contributor to myopathy is emerging.

Conclusions:

• Future research on mitochondrial stress in DMD requires standardized and carefully considered experimental designs to resolve conflicting data.
• Re-evaluating mitochondrial stress responses as adaptive mechanisms could offer new therapeutic avenues.
• Understanding mitochondrial remodeling in DMD and other muscular dystrophies is crucial for developing effective mitochondrial enhancement therapies.